ArticleGlobal health action
Addressing NCDs through research and capacity building in LMICs: lessons learned from tobacco control.
Article in Global health action. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Does raising tobacco taxes reduce the burden of non-communicable diseases? A panel data analysis of 152 countries.BMJ open · 2025Article
- Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization.International journal of environmental research and public health · 2023Review
- Defining indicators for the scoping stage of health impact assessment to evaluate tobacco control policy in the city of Beijing.BMC public health · 2023Review
- Building a 'Virtual Library': continuing a global collaboration to strengthen research capacity within Nepal and other low- and middle-income countries.Global health action · 2022Article
- Building Capacity for Global Cancer Research: Existing Opportunities and Future Directions.Journal of cancer education : the official journal of the American Association for Cancer Education · 2021Article
- Article
- Impact of a comprehensive tobacco control policy package on acute myocardial infarction and stroke hospital admissions in Beijing, China: interrupted time series study.Tobacco control · 2020Article
- First Africa non-communicable disease research conference 2017: sharing evidence and identifying research priorities.Journal of global health · 2019Article
- A narrative review of health research capacity strengthening in low and middle-income countries: lessons for conflict-affected areas.Globalization and health · 2019Review
- A scoping review of non-communicable disease research capacity strengthening initiatives in low and middle-income countries.Global health research and policy · 2019Article
- Training opportunities for noncommunicable diseases research in Latin America: A scoping review.Revista panamericana de salud publica = Pan American journal of public health · 2019Article
- Context-led capacity building in time of crisis: fostering non-communicable diseases (NCD) research skills in the Mediterranean Middle East and North Africa.Global health action · 2019Article
- The Vital Case for Global Health Investments by the US Government.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Confronting the global non-communicable diseases (NCDs) crisis requires a critical mass of scientists who are well versed in regional health problems and understand the cultural, social, economic, and political contexts that influence the effectiveness of interventions. Investments in global NCD research must be accompanied by contributions to local research capacity. The National Institutes of Health (NIH) and the Fogarty International Center have a long-standing commitment to supporting research capacity building and addressing the growing burden of NCDs in low- and middle-income countries. One program in particular, the NIH International Tobacco and Health Research and Capacity Building Program (TOBAC program), offers an important model for conducting research and building research capacity simultaneously. This article describes the lessons learned from this unique funding model and demonstrates how a relatively modest investment can make important contributions to scientific evidence and capacity building that could inform ongoing and future efforts to tackle the global burden of NCDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.